I’m a ’90s baby, which means medical dramas were at peak popularity during my childhood. Shows like “ER” and “Grey’s Anatomy” were among the big hits, often portraying a fantasy version of healthcare and hospital life. Throughout high school and college, I frequently indulged in this genre. I remember nights…

Winrevair (sotatercept-csrk), an injection therapy approved for adults with pulmonary arterial hypertension (PAH), is now covered by several of Canada’s publicly funded health programs. The therapy’s developer Merck, known as MSD outside the U.S. and Canada, announced that Winrevair has been added to the public drug formularies…

A decade later, I still remember standing in the kitchen on a phone call that would change my life. On that morning in March 2016, I left my apartment and returned nearly two weeks later with a pulmonary hypertension (PH) diagnosis. I never thought I’d reach this milestone: living…